Bloomberg News

Merck Tops Estimates on Diabetes Drug Sales

April 27, 2012

Bloomberg's Dominic Chu reports that Merck & Co., the second-largest U.S. drugmaker, reported first-quarter profit that beat analyst estimates on higher sales of its diabetes treatments. He speaks on Bloomberg Television's "Inside Track." (Source: Bloomberg)

Running Time: 01:08


We Almost Lost the Nasdaq
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus